共 50 条
- [1] PEOPLE (NCT03447678), a first-line phase II pembrolizumab trial, in negative and low PD-L1 advanced NSCLC: clinical outcomes and association with circulating immune biomarkersESMO OPEN, 2022, 7 (06)Lo Russo, G.Sgambelluri, F.Prelaj, A.Galli, F.Manglaviti, S.Bottiglieri, A.Di Mauro, R. M.Ferrara, R.Galli, G.Signorelli, D.De Toma, A.Occhipinti, M.Brambilla, M.Rulli, E.Triulzi, T.Torelli, T.Agnelli, L.Brich, S.Martinetti, A.Dumitrascu, A. D.Torri, VPruneri, G.Fabbri, A.de Braud, F.Anichini, A.Proto, C.Ganzinelli, M.Mortarini, R.Garassino, M. C.
- [2] PEOPLE (NTC03447678), a phase II trial to test pembrolizumab as first-line treatment in patients with advanced NSCLC with PD-L1 < 50%: a multiomics analysisJOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (06)Lo Russo, GiuseppePrelaj, ArselaDolezal, JamesBeninato, TeresaAgnelli, LucaTriulzi, TizianaFabbri, AlessandraLorenzini, DanieleFerrara, RobertoBrambilla, MartaOcchipinti, MarioMazzeo, LauraProvenzano, LeonardoSpagnoletti, AndreaViscardi, GiuseppeSgambelluri, FrancescoBrich, SilviaMiskovic, VanjaPedrocchi, Alessandra Laura GiuliaTrovo, FrancescoManglaviti, SaraGiani, ClaudiaAmbrosini, PaoloLeporati, RitaFranza, AndreaMcCulloch, JohnTorelli, TommasoAnichini, AndreaMortarini, RobertaTrinchieri, GiorgioPruneri, GiancarloTorri, ValterDe Braud, FilippoProto, ClaudiaGanzinelli, MonicaGarassino, Marina Chiara
- [3] PEOPLE (NTC03447678), a phase II trial to test pembrolizumab as first-line treatment in patients with advanced NSCLC with PD-L1 < 50%: A multiomics approach.JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)Garassino, Marina ChiaraProto, ClaudiaDolezal, James M.Prelaj, ArselaAgnelli, LucaTriulzi, TizianaFabbri, AlessandraFerrara, RobertoSgambelluri, FrancescoTorelli, TommasoBrich, SilviaManglaviti, SaraAnichini, AndreaMortarini, RobertaTrinchieri, GiorgioPruneri, GiancarloDe Braud, Filippo G.Torri, ValterGanzinelli, MonicaLo Russo, Giuseppe
- [4] PEOPLE (NTC03447678), a Phase II Trial to Test Biomarkers of Response to Pembrolizumab as First-Line Treatment in Advanced NSCLC Patients with PD-L1>50%JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : E10 - E10Dolezal, J.Lo Russo, G.Proto, C.Prelaj, A.Ganzinelli, M.Mortarini, R.Torri, V.Ferarra, R.Agnelli, L.Brich, S.Garassino, M. C.
- [7] Outcomes to first-line pembrolizumab in patients with advanced NSCLC and high PD-L1 expression: A Spanish multicentric studyANNALS OF ONCOLOGY, 2023, 34Piedra, A.Recio, S. MartinezGonzalez, A. HernandezBueno, M. T. MoranArriola, E.Recuero-Borau, J.Dols, M. CoboGonzalez, P. CordeiroMartinez, J. MosqueraGarcia-Campelo, M. R.Blanco, A. CallesAlvarez, R. M.Garcia, M. ZapataCasado, M. D. IslaPerez, A. CallejoGomez, P. IranzoJoaquin, A. BarbaSullivan, I. G.Felip, E.Majem, M.
- [8] Venous thrombotic events and impact on outcomes in patients treated with first-line single-agent pembrolizumab in PD-L1 ≥ 50% advanced non small cell lung cancerJOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (16) : 15095 - 15102Doubre, HeleneGreillier, LaurentJusteau, GregoireRicordel, CharlesSwalduz, AurelieCurcio, HubertBylicki, OlivierAuliac, Jean-BernardGuisier, FlorianBigay-Game, LaurenceBernardi, MariePinsolle, JulianAmrane, KarimDecroisette, ChantalDescourt, RenaudChouaid, ChristosGeier, Margaux
- [9] Venous thrombotic events and impact on outcomes in patients treated with first-line single-agent pembrolizumab in PD-L1 ≥ 50% advanced non small cell lung cancerJournal of Cancer Research and Clinical Oncology, 2023, 149 : 15095 - 15102Hélène DoubreLaurent GreillierGrégoire JusteauCharles RicordelAurélie SwalduzHubert CurcioOlivier BylickiJean-Bernard AuliacFlorian GuisierLaurence Bigay-GameMarie BernardiJulian PinsolleKarim AmraneChantal DecroisetteRenaud DescourtChristos ChouaidMargaux Geier
- [10] Post-progression outcomes of NSCLC patients with PD-L1 expression > 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world studyEUROPEAN JOURNAL OF CANCER, 2021, 148 : 24 - 35Cortellini, AlessioCannita, KatiaTiseo, MarcelloCortinovis, Diego L.Aerts, Joachim G. J., VBaldessari, CinziaGiusti, RaffaeleFerrara, Miriam G.D'Argento, EttoreGrossi, FrancescoGuida, AnnalisaBerardi, RossanaMorabito, AlessandroGenova, CarloAntonuzzo, LorenzoMazzoni, FrancescaDe Toma, AlessandroSignorelli, DiegoGelibter, AlainTargato, GiadaRastelli, FrancescaChiari, RitaRocco, DaniloGori, StefaniaDe Tursi, MicheleMansueto, GiovanniZoratto, FedericaFiletti, MarcoBracarda, SergioCitarella, FabrizioRussano, MarcoCantini, LucaNigro, OlgaButi, SebastianoMinuti, GabrieleLandi, LorenzaRicciardi, SerenaMigliorino, Maria R.Natalizio, SalvatoreSimona, CarnioDe Filippis, MarcoMetro, GiulioAdamo, VincenzoRusso, AlessandroSpinelli, Gian P.Di Maio, MassimoBanna, Giuseppe L.Friedlaender, AlexAddeo, AlfredoPinato, David J.